Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung Su

Showing results (301-310 of 394) with videos related to

Pageof 40
Sort By:
Gastroenterology|February 16, 2012
High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV loadTai-Chung Tseng, Chun-Jen Liu, Hung-Chih Yang, et al.
Hepatology (Baltimore, Md.)|August 23, 2011
Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral loadTai-Chung Tseng, Chun-Jen Liu, Hung-Chih Yang, et al.
The Journal of Infectious Diseases|September 12, 2012
Young chronic hepatitis B patients with nucleos(t)ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivationTai-Chung Tseng, Chun-Jen Liu, Tung-Hung Su, et al.
JHEP Reports : Innovation in Hepatology|December 13, 2023
HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negativeTai-Chung Tseng, Tetsuya Hosaka, Chun-Jen Liu, et al.
Gut Pathogens|June 17, 2023
Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver diseaseMeng-Ju Lin, Tung-Hung Su, Chieh-Chang Chen, et al.
Journal of Hepatology|February 2, 2020
HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosisTai-Chung Tseng, Chun-Jen Liu, Crystal T Chang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2021
Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort studyMargarita Papatheodoridi, Tung-Hung Su, Emilia Hadziyannis, et al.
Cancer|September 6, 2024
Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver diseaseFeng-Pai Tsai, Tung-Hung Su, Shang-Chin Huang, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 8, 2023
Serial increase and high alpha-fetoprotein levels predict the development of hepatocellular carcinoma in 6 monthsTung-Hung Su, Shan-Han Chang, Chi-Ling Chen, et al.
Environmental Toxicology and Pharmacology|October 13, 2018
Safrole induced cytotoxicity, DNA damage, and apoptosis in macrophages via reactive oxygen species generation and Akt phosphorylationKuang-Jen Chien, Ming-Ling Yang, Ping-Kun Tsai, et al.
Pageof 40

Showing results (301-310 of 394) with videos related to

Sort By:
Pageof 40
Gastroenterology|February 16, 2012
High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV loadTai-Chung Tseng, Chun-Jen Liu, Hung-Chih Yang, et al.
Hepatology (Baltimore, Md.)|August 23, 2011
Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral loadTai-Chung Tseng, Chun-Jen Liu, Hung-Chih Yang, et al.
The Journal of Infectious Diseases|September 12, 2012
Young chronic hepatitis B patients with nucleos(t)ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivationTai-Chung Tseng, Chun-Jen Liu, Tung-Hung Su, et al.
JHEP Reports : Innovation in Hepatology|December 13, 2023
HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negativeTai-Chung Tseng, Tetsuya Hosaka, Chun-Jen Liu, et al.
Gut Pathogens|June 17, 2023
Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver diseaseMeng-Ju Lin, Tung-Hung Su, Chieh-Chang Chen, et al.
Journal of Hepatology|February 2, 2020
HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosisTai-Chung Tseng, Chun-Jen Liu, Crystal T Chang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2021
Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort studyMargarita Papatheodoridi, Tung-Hung Su, Emilia Hadziyannis, et al.
Cancer|September 6, 2024
Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver diseaseFeng-Pai Tsai, Tung-Hung Su, Shang-Chin Huang, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 8, 2023
Serial increase and high alpha-fetoprotein levels predict the development of hepatocellular carcinoma in 6 monthsTung-Hung Su, Shan-Han Chang, Chi-Ling Chen, et al.
Environmental Toxicology and Pharmacology|October 13, 2018
Safrole induced cytotoxicity, DNA damage, and apoptosis in macrophages via reactive oxygen species generation and Akt phosphorylationKuang-Jen Chien, Ming-Ling Yang, Ping-Kun Tsai, et al.
Pageof 40